SCHEMBL9952984

SCHEMBL9952984

COc1ccc(Cn2c(C)c(C(=O)C(=O)Nc3ccnc(OC)c3)c3cc(OC)c(Cl)cc32)nc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 1/20 0.60
PLA2G2A P14555 4/20 0.37
ANO1 Q5XXA6 1/20 0.36
SCN10A Q9Y5Y9 1/20 0.35
MEN1 O00255 1/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
KMT2A Q03164 1/20 0.34
KDR P35968 2/20 0.34
CSF1R P07333 1/20 0.34
PDGFRB P09619 1/20 0.34
FLT3 P36888 1/20 0.34
MAPT P10636 4/20 0.33
PDGFRA P16234 1/20 0.33
RXFP1 Q9HBX9 1/20 0.33
ALDH1A1 P00352 1/20 0.33
PKM P14618 1/20 0.33
ALOX5AP P20292 1/20 0.33
PPARG P37231 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9953596 0.93 FAAH (0.65) FAAHSCN10ANPC1RAB9AMAPT
SCHEMBL9958836 0.92 FAAH (0.57) FAAHPLA2G2AANO1SCN10AMEN1
SCHEMBL9952229 0.91 FAAH (0.56) FAAHPLA2G2AANO1MEN1NPC1
SCHEMBL9953502 0.90 FAAH (0.65) FAAHSCN10ANPC1RAB9AMAPT
SCHEMBL9951898 0.89 FAAH (0.65) FAAHPLA2G2AMEN1NPC1RAB9A
SCHEMBL9959541 0.88 FAAH (0.72) FAAHPLA2G2AANO1MEN1NPC1
SCHEMBL9958563 0.87 FAAH (0.65) FAAHSCN10AKDRMAPTPDGFRA
SCHEMBL9958621 0.86 FAAH (0.67) FAAHPLA2G2ASCN10AMAPT
SCHEMBL9952056 0.86 FAAH (0.80) FAAHPLA2G2AMEN1KMT2AMAPT
SCHEMBL9958758 0.86 FAAH (0.71) FAAHPLA2G2AMEN1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9657012-B2 FAAH inhibitors IRONWOOD PHARMACEUTICALS, INC. (US) 2017-05-23 US disclosed
US-9657012-B2 FAAH inhibitors IRONWOOD PHARMACEUTICALS, INC. (US) 2017-05-23 US disclosed
US-9657012-B2 FAAH inhibitors IRONWOOD PHARMACEUTICALS, INC. (US) 2017-05-23 US disclosed
EP-2655356-B1 FAAH INHIBITORS IRONWOOD PHARMACEUTICALS INC (US) 2016-08-03 EP disclosed
EP-2655356-B1 FAAH INHIBITORS IRONWOOD PHARMACEUTICALS INC (US) 2016-08-03 EP disclosed
US-20150175599-A1 FAAH Inhibitors IRONWOOD PHARMACEUTICALS, INC. (US) 2015-06-25 US disclosed
WO-2014004676-A1 USE OF FAAH INHIBITORS AS NEUROPROTECTIVE AGENTS IN THE CNS IRONWOOD PHARMACEUTICALS, INC. (US) 2014-01-03 WO disclosed
EP-2655356-A1 FAAH INHIBITORS Ironwood Pharmaceuticals, Inc. (US) 2013-10-30 EP disclosed
WO-2012088469-A1 FAAH INHIBITORS IRONWOOD PHARMACEUTICALS, INC. (US) 2012-06-28 WO disclosed
WO-2012088469-A1 FAAH INHIBITORS IRONWOOD PHARMACEUTICALS, INC. (US) 2012-06-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150175599-A1 FAAH Inhibitors FAAH, FAAH2, ASAH1 FAAH 1/4885PLA2G2A 63/4885ANO1 3063/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.